News

Boosting the antibiotic arsenal

Photo of Bacteria

New strategy could enable existing drugs to kill bacteria that cause chronic infections. MIT researchers have discovered a way to make bacteria more vulnerable to a class of antibiotics known as quinolones, which include ciprofloxacin and are often used to treat infections such as Escherichia coli and Staphylococcus aureus. The…

Read More

CRISPR-carrying nanoparticles edit the genome

New delivery system developed by MIT team deletes disease-causing genes and reduces cholesterol. In a new study, MIT researchers have developed nanoparticles that can deliver the CRISPR genome-editing system and specifically modify genes in mice. The team used nanoparticles to carry the CRISPR components, eliminating the need to use viruses…

Read More

Microbiome Innovation and Pilot Grants

The Center for Microbiome Informatics and Therapeutics is pleased to announce a new funding opportunity for research grants. To learn more and apply, please visit the Microbiome Center website: https://microbiome.mit.edu/funding-opportunity-for-innovation-and-pilot-grants-2017/ Overview The Center for Microbiome Informatics and Therapeutics was founded to accelerate the development of therapeutics to treat microbiome-associated disease, with…

Read More

Arup Chakraborty elected to National Academy of Medicine

Arup K. Chakraborty, the Robert T. Haslam Professor of Chemical Engineering and founding director of MIT’s Institute for Medical Engineering and Science (IMES), has been elected to the National Academy of Medicine (NAM) in recognition of his distinguished contributions to medicine and health. Chakraborty, a professor of physics, chemistry, and biological…

Read More